Community Project Funding/Congressionally Directed Spending - Construction - For over 50 years, Maine Medical Center (MMC) has maintained a tradition of cardiac excellence, resulting in many firsts. MMC was the first hospital in Northern New England to offer Transcatheter Aortic Valve Replacement (TAVR) and Percutaneous Mitral Valve Repair System (MitraClip), as well as vascular surgeries such as aortic and thoracic aneurysm repair. All of these surgeries require an operating environment that supports both advanced imaging as found in a cardiac catheterization lab, and a sterile field as found in traditional operating rooms. The combination of these technologies form what is called a Hybrid Operating Room (Hybrid OR). The number of heart valve surgeries at MMC is projected to grow 23% over the next five years. Building Hybrid ORs in the new Malone Family Tower will increase access to the most sophisticated platform for complex cardiovascular surgeries in Northern New England. Currently MMC treats 240-250 TAVR cases annually, with 21 MitraClips placed to date. The length of stay for these procedures ranges from 2-3 days, compared to 7-10 days for open heart surgeries. Marco Diaz, MD, Chair of Maine Medical Center’s Department of Cardiovascular Medicine and Chief of the MaineHealth Cardiac Service Line states “Cardiovascular medicine has evolved dramatically over the past few decades, and the time has come for our procedural and surgical spaces to evolve as well. Our current spaces cannot accommodate the latest equipment and technology that are now considered the standard of care.” The new facility will enable MMC’s teams to collaborate in real time like never before, to provide: same-day combinations of coronary artery interventions and/or minimally invasive valve repair or replacement; endovascular treatment of thoracic aortic aneurysms; stent graft treatment for thoracic aortic aneurysm in combination with open aneurysm repair or with minimally invasive cardiovascular procedures; electrophysiology procedures, including lead extraction and replacement of pacemaker/ICD devices, Watchman procedures for left atrial appendage thromboembolism prevention, and Afib convergent maze procedures; combined open surgical and endovascular procedures for peripheral arterial disease; mechanical support procedures to include extra corporeal membrane oxygenation and Impella 5.5 support for complex coronary total occlusion interventions; and complex catheter-based therapy for congenital cardiac conditions. The proposed funding will provide equipment for a Hybrid Operating Room (Hybrid OR) with an operating environment that supports both advanced imaging as found in a cardiac catheterization lab, and a sterile field as found in traditional operating rooms. Hybrid ORs have significantly more sophisticated monitoring and electrical needs, including reinforced ceilings for boom mounted equipment; surgical illumination (500-1000 lux); and advanced imaging/fixed C-arm angiography, within a 700-1000 sq. ft. space. The proposed funding will provide a single plane with flex arm imaging system (a motorized ceiling suspended C-Arm); a mapping system; electrophysiological (EP) 3D patient interface unit and advanced cath location; a system of ceiling mount booms, surgical lights, equipment and ACC arms; an Imaging ultrasound scanner kiosk system with stand, 19" LED monitor and touch screen; hemodynamic monitoring system for cardiac cath lab, including EV1000 platform and finger cuff; an integrated surgery audio/visual system, including Hexavue integrated communication; a minimally invasive surgical scope video system, including light source, insufflator, etc.; a height-adjustable Surgical OR Table System/Patient Transfer System; an Anesthesia machine (FABIUS TIRO, trolley version); a Generator cardiac ablation system; a Cool Flow irrigation pump; an automated medication dispenser, and an anesthesia medication cart.